THE FDA yesterday approved Perrigo's Opill (norgestrel) for OTC use, making it the first hormonal oral contraceptive available in the US without a prescription.
Patrizia Cavazzoni, Director of the FDA's Center for Drug Evaluation and Research said, as roughly half the 6.1 million pregnancies in the US each year are unplanned, the OTC approval "is expected to remove barriers to access and reduce the risk of unintended pregnancies".
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jul 23
